Skip to main content
Fig. 1 | Radiation Oncology

Fig. 1

From: Time-window of early detection of response to concurrent chemoradiation in cervical cancer by using diffusion-weighted MR imaging: a pilot study

Fig. 1

MRI and DWI images of uterine cervical cancer in group CR ((a–b), before CCR; (c–d), postT1; (e–f), postT2; (g–h), postT3; (i–j), postT4; (k–l), postT5). At base-line MRI, axial T2-weighted images (a) show a hyperintense tumor with well-defined margin before therapy. At postT1 (c) and postT2 (e), no significant change in size was shown. At postT3 (g), tumor showed a decrease in size. At postT4, tumor reduced in size markedly (i). At postT5, no residual tumor could be seen on T2-weighted images (k). The ADC values were 0.816 × 10−3 mm2/s at base-line (b), 0.935 × 10−3 mm2/s at postT1 (d), 1.090 × 10−3 mm2/s at postT2 (f), 1.110 × 10−3 mm2/s at postT3 (h),1.280 × 10−3 mm2/s at postT4 (j), and 1.350 × 10−3 mm2/s at postT5 (l)

Back to article page